PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-0.34%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
105.72%
Gross profit growth above 1.5x FSLR's 31.73%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
57.70%
EBIT growth below 50% of FSLR's 274.21%. Michael Burry would suspect deeper competitive or cost structure issues.
46.08%
Operating income growth under 50% of FSLR's 274.21%. Michael Burry would be concerned about deeper cost or sales issues.
30.28%
Net income growth under 50% of FSLR's 469.21%. Michael Burry would suspect the firm is falling well behind a key competitor.
30.93%
EPS growth under 50% of FSLR's 455.56%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
30.93%
Diluted EPS growth under 50% of FSLR's 455.56%. Michael Burry would worry about an eroding competitive position or excessive dilution.
0.39%
Share count expansion well above FSLR's 0.23%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.39%
Diluted share count expanding well above FSLR's 0.19%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-27.51%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-15.58%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
1.68%
10Y revenue/share CAGR under 50% of FSLR's 461.62%. Michael Burry would suspect a lasting competitive disadvantage.
-53.23%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-39.91%
Negative 3Y CAGR while FSLR stands at 9.91%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-1801.75%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-208.25%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-14.01%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-845.00%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
5.36%
Positive 5Y CAGR while FSLR is negative. John Neff might view this as a strong mid-term relative advantage.
-718.62%
Negative 3Y CAGR while FSLR is 1001.51%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
-38.05%
Negative equity/share CAGR over 10 years while FSLR stands at 664.92%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-45.43%
Negative 5Y equity/share growth while FSLR is at 31.04%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-48.50%
Negative 3Y equity/share growth while FSLR is at 8.80%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
5.87%
AR growth is negative/stable vs. FSLR's 155.89%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
3.93%
We show growth while FSLR is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
0.70%
Asset growth at 50-75% of FSLR's 1.15%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
-5.90%
We have a declining book value while FSLR shows 0.99%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-9.60%
We’re deleveraging while FSLR stands at 40.98%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-3.71%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
1.93%
SG&A growth well above FSLR's 1.57%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.